KalVista Pharmaceuticals KALV
$ 8.47
4.7%
Quarterly report 2024-Q3
added 12-05-2024
KalVista Pharmaceuticals EV/EBITDA Ratio 2011-2024 | KALV
Annual EV/EBITDA Ratio KalVista Pharmaceuticals
2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|
-3.44 | -4.59 | -10.7 | -1.92 | -0.0957 | 0.857 | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
0.857 | -10.7 | -3.32 |